Clinical Trials Browser

Phase 1/2 × Hamartoma Syndrome, Multiple × Clear all

NCT06080165 2024-07-10

Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations

Phase 1/2 Withdrawn

Hamartoma Syndrome, Multiple

NCT00600275 2020-12-17

A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Hamartoma Syndrome, Multiple, Hereditary Sensory and Autonomic Neuropathies